Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
KAICO
AddedJun 25, 2026
UpdatedJul 6, 2026
KAICO

KAICO

Pre-Seed

KAICO produces recombinant proteins and vaccines using a silkworm-baculovirus expression system.

HQ
Fukuoka, Fukuoka, JP
Founded
2018
Overview
Compare
Fundraising
Employees
Website

KAICO is a biotech startup originating from Kyushu University that uses a proprietary silkworm-baculovirus expression system to produce target proteins. The platform leverages highly productive silkworm strains and gene design expertise to make high-quality proteins that are difficult to produce in other systems.

The company offers customized protein trial expression services and sells reagents, and it develops its own supplements plus animal and human vaccines. KAICO was established on April 2, 2018 and is based in Fukuoka, Japan.

KAICO - Similar Companies

Future Fields logo

Future Fields

futurefields.io

Kiko Labs logo

Kiko Labs

Kashikoi logo

Kashikoi

getkashikoi.com

Kaarya logo

Kaarya

Cocoon Biotech logo

Cocoon Biotech

cocoonbiotech.com

Kawa Objects logo

Kawa Objects

CarboCode logo

CarboCode

carbocode.com

HiKoa logo

HiKoa

Proteinea logo

Proteinea

proteinea.com

Protein Foundry logo

Protein Foundry

proteinfoundry.com

Kopra Bio logo

Kopra Bio

kopra.bio

Rogo logo

Rogo

rogo.ai

Liberation Labs logo

Liberation Labs

liberationlabs.com

Cajal logo

Cajal

caj.al

Hyku logo

Hyku

KAICO - Quick Facts

Who are KAICO's competitors?

Companies similar to KAICO include Future Fields, Kiko Labs, Kashikoi and Kaarya.

When was KAICO founded?

KAICO was founded in 2018.

Where is KAICO's headquarters located?

KAICO's headquarters is located in Fukuoka, Fukuoka, JP.

When was KAICO's last funding round?

KAICO's most recent funding round was for $20k (USD) in January 2022.

How much has KAICO raised to-date?

As of Jan 1, 2022, KAICO has raised a total of $20k (USD).

KAICO - Classification

Industry
  • Biotechnology